在重症监护室个性化启动替代疗法:基于强化学习的策略,在AKIKI随机对照试验中获得外部验证
François Grolleau1,2, François Petit1, Stéphane Gaudry3,4,5
1Université Paris Cité and Université Sorbonne Paris Nord, INSERM, INRAE, Center for Research in Epidemiology and StatisticS (CRESS), Paris, F-75004, France.
概括
这项研究开发了人工智能策略,以优化急性损伤 (AKI) 患者的替代疗法 (RRT) 启动. 这些策略改善了无医院日,减少了RRT使用,有助于临床决策.
科学领域:
- 关键护理医学 关键护理医学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 医疗保健中的人工智能
背景情况:
- 对急性损伤 (AKI) 及时启动替代疗法 (RRT) 是至关重要的,但复杂的,需要个性化决策.
- 当前的RRT启动协议可能无法充分考虑AKI和患者特征的动态性质.
研究的目的:
- 开发和验证在重症监护病房 (ICU) 中使用强化学习启动RRT的最佳策略.
- 为了改善患者的结果,以无住院日来衡量,并优化RRT利用.
主要方法:
- 使用MIMIC-III数据库进行战略开发,使用AKIKI试验进行外部验证.
- 采用双倍强大的估计器来学习基于临床数据的RRT启动时间.
- 为RRT启动制定了一个"粗的战略"和一个"严格的战略".
主要成果:
- 外部验证显示",粗"和"严格"策略在第60天的无医院日分别提高了13.7天和14.9天,与当前的最佳实践相比.
- "严格策略"减少了患者在3天内启动RRT的14%,而在最佳实践下为38%.
- 开发的策略是实用的,可以解释为临床决策支持.
结论:
- 人工智能驱动的策略可以增强临床决策,在AKI患者中启动RRT.
- 实施这些策略可能会导致更好的患者结果和更明智地使用RRT.
- 已成功开发和验证了用于RRT启动的动态决策支持系统.
相关概念视频
01:27Dialysis
309
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
309
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
429
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
429